Product
Diroximel Fumarate
Aliases
BIIB098, VUMERITY
Name
Vumerity
INN Name
diroximel fumarate
FDA Approved
Yes
5 clinical trials
1 organization
2 indications
1 document
Indication
Multiple SclerosisIndication
Relapsing Multiple SclerosisClinical trial
Vumerity (Diroximel Fumarate) Prospective MS Pregnancy Exposure RegistryStatus: Recruiting, Estimated PCD: 2032-07-06
Clinical trial
A Prospective, Observational Study Evaluating Persistence on Treatment, Safety, Tolerability, and Effectiveness of Diroximel Fumarate in the Real-World Setting (EXPERIENCE-US Study)Status: Terminated, Estimated PCD: 2023-04-14
Clinical trial
Pregnancy Outcomes in Women Exposed to Diroximel FumarateStatus: Recruiting, Estimated PCD: 2031-01-17
Clinical trial
A Prospective, Observational Study Evaluating Persistence on Treatment, Safety, Tolerability, and Effectiveness of Diroximel Fumarate in the Real-World Setting (EXPERIENCE-CA+IL Study)Status: Terminated, Estimated PCD: 2023-04-14
Clinical trial
An Observational Study Utilising Data From Big MS Data Registries to Evaluate the Long-Term Safety of Vumerity and TecfideraStatus: Not yet recruiting, Estimated PCD: 2032-12-01
Document
DailyMed Label: VumerityOrganization
Biogen Inc.